Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
CHARLOTTE, N.C., April 7, 2015 (GLOBE NEWSWIRE) -- Capitala Finance Corp. (the "Company") (Nasdaq:CPTA) today announced the commencement of an underwritten offering of 3,500,000 shares of its common...
-
TORONTO, April 7, 2015 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (Nasdaq:TRIL) (TSX:TR) an immuno-oncology company developing innovative therapies for the treatment of cancer, today announced...
-
NORTHBROOK, Ill., April 7, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, announced today that a 20-to-1 reverse split of...
-
ADVISORY, Apr. 07, 2015 (GLOBE NEWSWIRE) -- What: Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease,...
-
ADVISORY, Apr. 07, 2015 (GLOBE NEWSWIRE) -- What: PDC Energy, Inc. (Nasdaq:PDCE), an independent oil and natural gas company, will visit the Nasdaq MarketSite in Times Square. In...
-
SHANGHAI, China and PALO ALTO, Calif., April 7, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (Nasdaq:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of...
-
ATLANTA, GA., April 7, 2015 (GLOBE NEWSWIRE) -- ExamWorks Group, Inc. (NYSE:EXAM) announced today that it intends to commence an offering of $500 million in aggregate principal of senior unsecured...
-
HOUSTON and NEUQUEN CITY, Argentina, April 6, 2015 (GLOBE NEWSWIRE) -- Eco-Stim Energy Solutions, Inc. (OTC:ESES) ("EcoStim" or the "Company") announced today that it has received confirmation that...
-
MCLEAN, Va., April 6, 2015 (GLOBE NEWSWIRE) -- Gladstone Investment Corporation (Nasdaq:GAIN) (the "Company") today announced that in connection with the offering of its common stock, par value $0.001...
-
NEW YORK, April 6, 2015 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of...